Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy

  1. Barros-Tizón, J.C.
  2. Torres, M.L.
  3. Blanco, I.
  4. Martínez, M.T.
Journal:
Therapeutic Advances in Respiratory Disease

ISSN: 1753-4666,  1753-4658

Year of publication: 2012

Volume: 6

Issue: 2

Pages: 67-78

Type: Article

DOI: 10.1177/1753465812438387 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus